← Back to headlines
Enliven Therapeutics CMO Sells $1.2 Million in Company Shares
The Chief Medical Officer of Enliven Therapeutics (ELVN) sold 40,000 shares of the company's stock, totaling $1.2 million.
28 Mar, 18:17 — 28 Mar, 18:17
Sources
Showing 1 of 1 sources
